Glenmark to start trial of favipiravir combo drug for moderate covid-19 symptoms
(World News Science)

NEW DELHI: Glenmark Pharmaceuticals Ltd on Tuesday announced that it will soon start a study to test the combined efficacy of two antiviral drugs--favipiravir and umifenovir--as a potential covid-19 treatment strategy. While the company is already conducting a trial of favipiravir on mild-to-moderate covid-19 symptoms, the combination drug is aimed at moderate infection in...